Abstract: The present disclosure provides methods for determining whether a subject is infected with lymphocytic choriomeningitis virus (LCMV). These methods include obtaining a sample from a subject with increased susceptibility to LCMV infection, contacting the sample with one or more compositions for detecting LCMV, and determining whether the one or more compositions for detecting LCMV is associated with a marker of LCMV from the sample, wherein detection of an association indicates that that the subject is infected with LCMV.
Type:
Grant
Filed:
January 6, 2012
Date of Patent:
November 11, 2014
Assignee:
Bioscience Slovakia
Inventors:
Jana Tomaskova, Juraj Kopacek, Jaromir Pastorek, Silvia Pastorekova